![David Moore](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Moore
Director/Board Member at
CORIUM INTERNATIONAL INC
Net worth: 324 198 $ as of 2026-06-29
Profile
David S.
Moore is Chairman at Novasenta, Inc. since 2023.
Holds director positions at Corium LLC (Massachusetts) and Tremeau Pharmaceuticals, Inc. Serves as Independent Director at Corvus Pharmaceuticals, Inc. starting 2025.
Senior Vice President-US Commercial at Novo Nordisk, Inc. since 2017.
Partner at Gurnet Point Capital LLC since 2020.
Former Chief Executive Officer at Roivant Sciences, Inc. from 2019 to 2020.
Independent Director at Sirona Biochem Corp.
from 2014 to 2017.
Director at Alladapt Immunotherapeutics, Inc. President & Chief Commercial Officer at Cempra, Inc. from 2016 to 2019.
Chief Business Officer at OCERA Therapeutics LLC in 2013.
Chief Business Officer at Tranzyme Pharma, Inc. (Canada) from 2012 to 2013.
Education includes undergraduate studies at Thomas Jefferson University and Towson University, and an MBA from Lehigh University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-06-10 | 21,700 ( 0.03% ) | 324 198 $ | 2026-06-29 |
David Moore active positions
| Companies | Position | Start |
|---|---|---|
| CORIUM INTERNATIONAL INC | Director/Board Member | - |
| CORVUS PHARMACEUTICALS, INC. | Director/Board Member | 2025-10-01 |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Develops biological medicines | Corporate Officer/Principal | 2017-07-31 |
Gurnet Point Capital LLC
 Gurnet Point Capital LLC Investment ManagersFinance Gurnet Point Capital invests in companies located in the United States. The firm targets companies operating in the fields of life sciences and medical technologies sector. It provides financing for buyout stage capital requirements. It also acquires majority stake and control positions. | Private Equity Investor | 2020-02-29 |
Tremeau Pharmaceuticals, Inc.
 Tremeau Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and delivers non-opioid pain therapies for people | Director/Board Member | - |
Novasenta, Inc.
 Novasenta, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for immune-mediated diseases and cancer | Chairman | 2022-12-31 |
Former positions of David Moore
| Companies | Position | End |
|---|---|---|
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs | Chief Executive Officer | 2020-02-29 |
Cempra, Inc.
 Cempra, Inc. Pharmaceuticals: MajorHealth Technology Operates as a holding company with interest in manufacturing pharmaceutical products | President | 2019-04-30 |
| SIRONA BIOCHEM CORP. | Director/Board Member | 2017-10-26 |
| ░░░░░ ░░░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░ ░░░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Training of David Moore
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
31
1st degree connections
15
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 15 |
|---|---|
Thomas Jefferson University
 Thomas Jefferson University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sirona Biochem Corp.
 Sirona Biochem Corp. Pharmaceuticals: MajorHealth Technology Develops cosmetic and pharmaceutical active ingredients | Health Technology |
Cempra, Inc.
Cempra, Inc. Pharmaceuticals: MajorHealth Technology Operates as a holding company with interest in manufacturing pharmaceutical products | Health Technology |
Corvus Pharmaceuticals, Inc.
 Corvus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides anticancer immuno-oncology drugs | Health Technology |
OCERA Therapeutics LLC
 OCERA Therapeutics LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Health Technology |
Lehigh University
 Lehigh University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Towson University
 Towson University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Corium International, Inc.
 Corium International, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of novel neuroscience therapies | Health Technology |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Develops biological medicines | Health Technology |
Tranzyme Pharma, Inc. (Canada) | |
Gurnet Point Capital LLC
Gurnet Point Capital LLC Investment ManagersFinance Gurnet Point Capital invests in companies located in the United States. The firm targets companies operating in the fields of life sciences and medical technologies sector. It provides financing for buyout stage capital requirements. It also acquires majority stake and control positions. | Finance |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs | Health Technology |
Tremeau Pharmaceuticals, Inc.
Tremeau Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and delivers non-opioid pain therapies for people | Health Technology |
Alladapt Immunotherapeutics, Inc.
 Alladapt Immunotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics targeting food allergy | Health Technology |
Novasenta, Inc.
Novasenta, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for immune-mediated diseases and cancer | Health Technology |
- Stock Market
- Insiders
- David Moore
